Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuko Hachiya

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 4, 2008
[Evaluation of an anti-HIV-1/2 antibodies detection kit based on counting immunoassay in whole blood]Atsuko Hachiya, Izumi Suetake, Hirokazu Kakuda, et al.
Virology|October 13, 2005
Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressureHiroyuki Gatanaga, Atsuko Hachiya, Satoshi Kimura, et al.
Frontiers in Reproductive Health|October 28, 2022
Nation-Wide Viral Sequence Analysis of HIV-1 Subtype B Epidemic in 2003-2012 Revealed a Contribution of Men Who Have Sex With Men to the Transmission Cluster Formation and Growth in JapanTeiichiro Shiino, Atsuko Hachiya, Junko Hattori, et al.
The Journal of Antibiotics|June 23, 2011
The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activityAtsushi Takahashi, Junji Inokoshi, Atsuko Hachiya, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2010
Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirineHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2021
Phylodynamic analysis reveals changing transmission dynamics of HIV-1 CRF01_AE in Japan from heterosexuals to men who have sex with menMachiko Otani, Teiichiro Shiino, Makiko Kondo, et al.
Journal of Virological Methods|March 13, 2019
Identifying integration sites of the HIV-1 genome with intact and aberrant ends through deep sequencingHirotaka Ode, Ayumi Kobayashi, Masakazu Matsuda, et al.
AIDS (London, England)|February 18, 2010
Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistanceHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
Journal of Virological Methods|June 25, 2003
"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrationsAtsuko Hachiya, Saori Matsuoka-Aizawa, Kiyoto Tsuchiya, et al.
Journal of Virology|December 13, 2002
Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replicationSaori Matsuoka-Aizawa, Hironori Sato, Atsuko Hachiya, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 4, 2008
[Evaluation of an anti-HIV-1/2 antibodies detection kit based on counting immunoassay in whole blood]Atsuko Hachiya, Izumi Suetake, Hirokazu Kakuda, et al.
Virology|October 13, 2005
Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressureHiroyuki Gatanaga, Atsuko Hachiya, Satoshi Kimura, et al.
Frontiers in Reproductive Health|October 28, 2022
Nation-Wide Viral Sequence Analysis of HIV-1 Subtype B Epidemic in 2003-2012 Revealed a Contribution of Men Who Have Sex With Men to the Transmission Cluster Formation and Growth in JapanTeiichiro Shiino, Atsuko Hachiya, Junko Hattori, et al.
The Journal of Antibiotics|June 23, 2011
The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activityAtsushi Takahashi, Junji Inokoshi, Atsuko Hachiya, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2010
Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirineHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2021
Phylodynamic analysis reveals changing transmission dynamics of HIV-1 CRF01_AE in Japan from heterosexuals to men who have sex with menMachiko Otani, Teiichiro Shiino, Makiko Kondo, et al.
Journal of Virological Methods|March 13, 2019
Identifying integration sites of the HIV-1 genome with intact and aberrant ends through deep sequencingHirotaka Ode, Ayumi Kobayashi, Masakazu Matsuda, et al.
AIDS (London, England)|February 18, 2010
Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistanceHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
Journal of Virological Methods|June 25, 2003
"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrationsAtsuko Hachiya, Saori Matsuoka-Aizawa, Kiyoto Tsuchiya, et al.
Journal of Virology|December 13, 2002
Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replicationSaori Matsuoka-Aizawa, Hironori Sato, Atsuko Hachiya, et al.
Pageof 6